aclens.com - Acuvue Contact Lenses for Less    Shop Warby Parker Online   



Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


Contact Lenses News:

Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


SKU-J11-551 Acuvue Oasys for Astigmatism from 1 800 get lens  sku

Acuvue Oasys for Astigmatism - J11-551 by Johnson & Johnson

Item description: This Contact Lenses Toric Lenses product is by Johnson & Johnson - Acuvue Oasys for Astigmatism is specially designed for people with astigmatism. That's because the Accelerated Stabilization Design of the lens harnesses the power of the blink to create a lens that remains positioned correctly and gives you crisp, steady vision all day long. Acuvue Oasys for Astigmatism offers exceptional comfort throughout the day with Hydraclear Plus,the next generation of proprietary technology that creates a more wettable, ultra smooth contact lens. So now you can have great vision and great comfort no matter where your day takes you.These lenses are tinted for ease of handling and will not change the color of your eye. The tint is simply designed to facilitate locating the contact lenses in solution.... Learn More

Manufacturer: Johnson & Johnson

Keywords: Acuvue Oasys for Astigmatism Johnson & Johnson Toric Lenses

1-800-GET-LENS

Store: We provide customers with top brands like Bausch&Lomb and Johnson&Johnson - brands that customers know and trust.

Category: Toric Lenses

$41.50

See the Price of Acuvue Oasys for Astigmatism

You may also consider:

  Acuvue Oasys for Presbyopia
Your eyes can feel dry and tired in challenging environments, inside or out. The Acuvue Oasys for Presbyopia, featuring next generation HYDRACLEAR Plus silicone hydrogel technology, help keep your eyes fresh and comfortable. ...See The Price
 
  1-Day Acuvue Moist 90PK
1-Day Acuvue Moist are the new daily disposable contact lenses from Johnson & Johnson. Designed to help your eyes stay moist and fresh all day 1-Day Acuvue Moist incorporate a new technology to create a silky smooth moisture cushion throughout the lens.These lenses are tinted for ease of handling and will not change the color of your eye. The tint is simply designed to facilitate locating the contact lenses in solution. They also contain an inside-out 123 indicator to help ensure proper applicat ...See The Price
 
  1-Day Acuvue TruEye
1 Day Acuvue TruEye are daily disposable silicone hydrogel contact lenses manufactured by Johnson & Johnson (Vistakon). ...See The Price